Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention. [electronic resource]
Producer: 20020925Description: 203-9 p. digitalISSN:- 0929-5305
- Abciximab
- Adult
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- administration & dosage
- Creatine Kinase -- blood
- Drug Therapy, Combination
- Eptifibatide
- Female
- Fibrinolytic Agents -- administration & dosage
- Hemorrhage -- etiology
- Heparin -- administration & dosage
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Length of Stay
- Male
- Middle Aged
- Peptides -- administration & dosage
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Prospective Studies
- Recurrence
- Retrospective Studies
- Survival Rate
- Tirofiban
- Treatment Outcome
- Tyrosine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.